Clinical trial
NEoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed (NEEDS Trial)
NCT04460352 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NEoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed (NEEDS Trial)
- Lead sponsor
- Karolinska University Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 27, 2020
- Completion date
- December 31, 2031
- Enrollment
- 1,020 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.